Thus, as expected, TP53 was the most commonly altered gene (82%) in osteosarcoma PDX models (Figure 2C), which also demonstrate global copy number changes, consistent with the high prevalence of complex genomic rearrangements found in this tumor type (Figure S4). This evidence concerns the gene TP53 and osteosarcoma.